Cipla (CPLFY) 3-Year EBITDA Growth Rate : 13.40% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Cipla 3-Year EBITDA Growth Rate?

Cipla's EBITDA per Share for the three months ended in Dec. 2023 was $0.26.

During the past 12 months, Cipla's average EBITDA Per Share Growth Rate was 27.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 13.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 10.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cipla was 24.60% per year. The lowest was 1.80% per year. And the median was 12.70% per year.

Competitive Comparison of Cipla's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, Cipla's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cipla's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipla's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cipla's 3-Year EBITDA Growth Rate falls into.

Cipla 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Cipla (OTCPK:CPLFY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Cipla 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cipla's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cipla (CPLFY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipla Ltd (OTCPK:CPLFY) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CIPLA:India 500087:India

Address

Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013

Website

https://www.cipla.com

Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large global presence. Cipla's growth strategy focuses on new product launches. It has two segments Pharmaceuticals and new ventures.